IN BRIEF: EDX Medical inks 3-year services deal with Royal Marsden

Related news

EDX Medical Group PLC - Cambridge, England-based firm that develops digital diagnostic products and services to treat cancer, heart disease, and infectious diseases - Signs master services agreement with Royal Marsden NHS Foundation Trust. The agreement will see EDX supply services to Royal Marsden over a three-year period. EDX Medical Founder & Chief Scientific Officer Chris Evans comments: ‘I am delighted EDX Medical has now been appointed as a supplier of diagnostic solutions and services to help serve the needs of one of the world’s most eminent cancer hospitals.’

Current stock price: 12.75 pence

12-month change: up 24%

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Contract wins

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.